An early-phase study of azacitidine and lenalidomide for untreated elderly acute myeloid leukemia (AML) patients

被引:0
|
作者
Pollyea, D. A.
Kohrt, H. E.
Rajwanshi, R.
Gallegos, L.
Berube, C.
Coutre, S. E.
Gotlib, J. R.
Liedtke, M.
Mitchell, B. S.
Medeiros, B. C.
机构
[1] Stanford Canc Ctr, Stanford, CA USA
[2] Stanford Univ, Sch Med, Palo Alto, CA 94304 USA
关键词
D O I
10.1200/jco.2010.28.15_suppl.tps280
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
TPS280
引用
收藏
页数:1
相关论文
共 50 条
  • [31] CC-486 (Oral Azacitidine) Monotherapy in Patients with Acute Myeloid Leukemia (AML)
    Savona, Michael R.
    Gore, Steven D.
    Kolibaba, Kathryn S.
    Ukrainskyj, Stacey M.
    Kumar, Keshava
    Dong, Qian
    Hetzer, Joel
    Skikne, Barry
    Garcia-Manero, Guillermo
    BLOOD, 2015, 126 (23)
  • [32] The Role of Azacitidine in the Treatment of Elderly Patients with Acute Myeloid Leukemia: Results of a Retrospective Multicenter Study
    Tombak, Anil
    Ucar, Mehmet Ali
    Akdeniz, Aydan
    Tiftik, Eyup Naci
    Sahin, Deniz Goren
    Akay, Olga Meltem
    Yildirim, Murat
    Nevruz, Oral
    Kis, Cem
    Gurkan, Emel
    Solmaz, Serife Medeni
    Ozcan, Mehmet Ali
    Yildirim, Rahsan
    Berber, Ilhami
    Erkurt, Mehmet Ali
    Tuglular, Tulin Firatli
    Tarkun, Pinar
    Yavasoglu, Irfan
    Dogu, Mehmet Hilmi
    Sari, Ismail
    Merter, Mustafa
    Ozcan, Muhit
    Yildizhan, Esra
    Kaynar, Leylagul
    Mehtap, Ozgur
    Uysal, Ayse
    Sahin, Fahri
    Salim, Ozan
    Sungur, Mehmet Ali
    TURKISH JOURNAL OF HEMATOLOGY, 2016, 33 (04) : 273 - 280
  • [33] A Phase II Study of Azacitidine and Venetoclax as Maintenance Therapy in Patients With Acute Myeloid Leukemia
    Bazinet, Alexandre
    Kantarjian, Hagop
    Borthakur, Gautam
    Yilmaz, Musa
    Bose, Prithviraj
    Jabbour, Elias
    Alvarado, Yesid
    Chien, Kelly
    Pemmaraju, Naveen
    Takahashi, Koichi
    Short, Nicholas
    Daver, Naval
    Issa, Ghayas
    Jain, Nitin
    Bull-Linderman, Debra
    DiNardo, Courtney
    Montalban-Bravo, Guillermo
    Garcia-Manero, Guillermo
    Sasaki, Koji
    Ravandi, Farhad
    Kadia, Tapan
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S239 - S240
  • [34] Phase I dose escalation study of bortezomib in combination with lenalidomide in patients with myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML)
    Amrein, Philip C.
    Attar, Eyal C.
    Fathi, Amir Tahmasb
    McAfee, Steven L.
    Wadleigh, Martha
    DeAngelo, Daniel J.
    Steensma, David P.
    Foster, Julia
    Stone, Richard M.
    Neuberg, Donna S.
    Ballen, Karen K.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [35] Phase 2 Study of ASTX727 (cedazuridine/decitabine) Plus Venetoclax in Patients with Relapsed/Refractory Acute Myeloid Leukemia (AML) or Previously Untreated, Elderly Patients with AML Unfit for Chemotherapy
    Abuasab, Tareq
    Garcia-Manero, Guillermo
    Short, Nicholas
    Alvarado, Yesid
    Issa, Ghayas C.
    Islam, Rubiul
    Maiti, Abhishek
    Yilmaz, Musa
    Jain, Nitin
    Masarova, Lucia
    Kornblau, Steven M.
    Jabbour, Elias
    Pemmaraju, Naveen
    Montalban-Bravo, Guillermo
    Pierce, Sherry A.
    DiNardo, Courtney D.
    Kadia, Tapan M.
    Daver, Naval
    Konopleva, Marina
    Kantarjian, Hagop
    Ravandi, Farhad
    BLOOD, 2022, 140 : 3324 - 3326
  • [36] A retrospective study of comorbidities and complications in elderly acute myeloid leukemia (AML) patients in the US
    Dhopeshwarkar, Neil
    Wang, Xuehong
    Iqbal, Shahed
    Salas, Maribel
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [37] Azacitidine as the post-remission therapy for elderly patients with acute myeloid leukemia
    Yamamoto, Ryusuke
    Yokoyama, Akihiro
    Yoneda, Mie
    Ohashi, Kota
    Hosoda, Toru
    Kagoo, Toshiya
    Boku, Saigen
    Ueno, Hironori
    Yano, Takahiro
    ANNALS OF HEMATOLOGY, 2014, 93 (12) : 2081 - 2082
  • [38] An open, phase I study of cediranib in patients with acute myeloid leukemia (AML)
    Fiedler, Walter
    Mesters, Rolf
    Heuser, Michael
    Ehninger, Gerhard
    Ottman, Oliver G.
    Berdel, Wolfgang E.
    Zirrgiebel, Ute
    Robertson, Jane
    Puchalski, Thomas A.
    Brave, Sandra R.
    Juergensmeier, Juliane M.
    Serve, Hubert
    BLOOD, 2007, 110 (11) : 273A - 273A
  • [39] Pracinostat in Combination with Azacitidine Produces a High Rate and Rapid Onset of Disease Remission in Patients with Previously Untreated Acute Myeloid Leukemia (AML)
    Garcia-Manero, Guillermo
    Atallah, Ehab
    Odenike, Olatoyosi
    Medeiros, Bruno C.
    Cortes, Jorge E.
    Esquibel, Vanessa
    Cha, Steven
    Khaled, Samer K.
    BLOOD, 2014, 124 (21)
  • [40] Azacitidine as the post-remission therapy for elderly patients with acute myeloid leukemia
    Ryusuke Yamamoto
    Akihiro Yokoyama
    Mie Yoneda
    Kota Ohashi
    Toru Hosoda
    Toshiya Kagoo
    Saigen Boku
    Hironori Ueno
    Takahiro Yano
    Annals of Hematology, 2014, 93 : 2081 - 2082